Juan D. Broceta-Unciti
Cordoba, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Neuroprotective Efficacy of Betulinic Acid Hydroxamate, a B55α/PP2A Activator, in Acute Hypoxia-Ischemia-Induced Brain Damage in Newborn Rats.
Journal: Translational stroke research
Published: October 01, 2021
Betulinic Acid Hydroxamate is Neuroprotective and Induces Protein Phosphatase 2A-Dependent HIF-1α Stabilization and Post-transcriptional Dephosphorylation of Prolyl Hydrolase 2.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: July 07, 2021
Agathadiol, a labdane diterpenoid from juniper berries, is a positive allosteric modulator of CB1R.
Journal: Fitoterapia
Published: June 25, 2021
(+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB1R antagonist/CB2R agonist that prevents diabetic nephropathy in mice.
Journal: Pharmacological research
Published: November 23, 2020
Isomeric O-methyl cannabidiolquinones with dual BACH1/NRF2 activity.
Journal: Redox biology
Published: June 16, 2020
Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease.
Journal: Acta pharmacologica Sinica
Published: April 28, 2020
The dimerization of Δ 9-tetrahydrocannabinolic acid A (THCA-A).
Journal: Acta pharmaceutica Sinica. B
Published: March 18, 2019
Drug "Clicking" on Cell-Penetrating Fluorescent Nanoparticles for In Cellulo Chemical Proteomics.
Journal: Bioconjugate chemistry
Published: August 21, 2018
Tracking cell proliferation using a nanotechnology-based approach.
Journal: Nanomedicine (London, England)
Published: May 18, 2017
New Approaches to Overcome Transport Related Drug Resistance in Trypanosomatid Parasites.
Journal: Frontiers in pharmacology
Published: July 24, 2016
Last Updated: 09/26/2026